ClinConnect ClinConnect Logo
Search / Trial NCT04241471

Incision and Loop Drainage Utilizing a Novel Technique for Management of Cutaneous Abscess in an Adult Population

Launched by BRYAN MALCOLM · Jan 24, 2020

Trial Information

Current as of April 25, 2025

Withdrawn

Keywords

Emergency Medicine Abscess Incision And Drainage Incision And Loop Drainage Sterile Glove

ClinConnect Summary

Practicing medicine in an austere environment is fraught with challenges. One primary challenge is that clinicians will frequently be practicing without the supplies needed for specific indicated purpose. For treatment of a cutaneous abscess, sterile gloves are readily available whether at home or when deployed. It can be much more difficult to come across a penrose or vessel loop. In addition, follow up for wound repacking and reassessment is a struggle. Patients may have to move from location to location or have work hours that make it difficult to return to the clinic. The loop technique...

Gender

ALL

Eligibility criteria

  • \*\*Patients must be able to get care at Nellis Air Force Base (a military installation) in order to participate in this study\*\*
  • Inclusion Criteria:
  • Active Duty and DoD beneficiaries aged 18 to 65 years old.
  • Abscess that requires drainage.
  • Exclusion Criteria:
  • Abscess of the hand, foot, or face, immunocompromised by disease or medications.
  • Temperature greater than 100.4 degrees Fahrenheit.
  • Systolic blood pressure less than 90 mmHG.
  • Abscess is too small to treat with incision and drainage (as seen on ultrasound).
  • Patient is too ill to be included in the study determined by clinical judgement of the treating provider.

Trial Officials

Paul F Crawford, MD

Study Director

United States Air Force

About Bryan Malcolm

Bryan Malcolm is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With extensive experience in the pharmaceutical and biotechnology sectors, he focuses on innovative therapies and cutting-edge treatments across various therapeutic areas. Bryan prioritizes collaboration with research institutions and healthcare professionals to ensure rigorous study designs and ethical standards. His leadership fosters an environment of transparency and integrity, driving the successful execution of clinical trials that aim to bring new solutions to market while maintaining the highest levels of patient safety and compliance.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials